2026 NPPES data Hematology & Oncology Physician NPI 1851385330 MD
Verify on CMS →

Michael Bergen, MD

Hematology & Oncology Physician in Montrose, Colorado.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
618
Medicare Part D claims · 119 beneficiaries · Hematology & Oncology Physician avg: 847

What the federal data shows

Michael Bergen, MD filed 618 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Montrose, Colorado.

618
Part D claims, 2023

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Michael Bergen, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

618 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Michael Bergen, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Michael Bergen, MD?

Quality data not reported

NPI registry status

Active

Issued 09/09/2005

NPI 1851385330

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,232 US NPIs in this specialty

Medicare Part D claims

618 27% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Colorado

How Hematology & Oncology Physician compares to other specialties among Colorado providers

Colorado providers
Behavior Technician7.8%Mental Health Counselor6.2%Physical Therapist4.2%Clinical Social Worker4.2%Professional Counselor3.7%Registered Nurse3.6%Hematology & Oncology Physic…0.1%
Largest specialties in Colorado (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Michael Bergen, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 600 S 5TH ST, Montrose, CO, 81401, with a listed phone of (970) 497-8001. NPI 1851385330 was issued on 09/09/2005.

Medicare Part D records for calendar year 2023 show 618 prescription claims written by this provider, covering 119 Medicare beneficiaries and totaling roughly $2.1 million in drug spend, with an opioid prescribing rate of 7.0%.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

600 S 5TH ST
Montrose, CO 81401

Provider Details

NPI 1851385330
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 09/09/2005

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

618
Total Claims
$2.1M
Total Drug Cost
119
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
925
Total Day Supply
24,897
Generic Drug Cost
$197K
Opioid Claims
43 (7.0% rate)
Antibiotic Claims
21

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
2.14
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Michael Bergen, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
57
Xtandi
Enzalutamide
31
Dexamethasone
29
Prednisone
29
Ninlaro
Ixazomib Citrate
27
Acyclovir
24
Revlimid
Lenalidomide
23
Oxycodone Hcl
21
Gabapentin
20
Bicalutamide
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Michael Bergen, MD fits within the Hematology & Oncology Physician landscape nationally.

11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Michael Bergen, MD's 618 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Colorado

Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as Bergen.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Colorado medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Michael Bergen, MD's specialty?
Michael Bergen, MD specializes in Hematology & Oncology Physician and practices in Montrose, Colorado. Credentials: MD.
How much does Michael Bergen, MD prescribe under Medicare Part D?
In 2023, Michael Bergen, MD wrote 618 Medicare Part D claims totaling $2.1M in drug costs for 119 beneficiaries.
Where is Michael Bergen, MD located?
Michael Bergen, MD is located at 600 S 5TH ST, Montrose, CO, 81401. Phone: (970) 497-8001.
What is Michael Bergen, MD's NPI number?
Michael Bergen, MD's National Provider Identifier (NPI) is 1851385330, issued on 09/09/2005.
Does Michael Bergen, MD prescribe opioids?
Yes, Michael Bergen, MD had 43 opioid claims in 2023 with an opioid prescribing rate of 7.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Michael Bergen, MD prescribe most often?
Based on 2023 Medicare Part D data, Michael Bergen, MD's most frequently prescribed drugs include Letrozole, Xtandi, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Bergen, MD accept Medicare?
Michael Bergen, MD appears in CMS Medicare data with 618 Part D claims and 119 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Bergen, MD's credentials?
Michael Bergen, MD's NPI is 1851385330 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the editorial process.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.